View Older Stories View More Recent Stories

Mar 31, 2023 10:00AM Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
Mar 29, 2023 05:24PM Form SC 13D/A Terns Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Mar 27, 2023 07:00AM ArriVent Biopharma Closes $155 Million Oversubscribed Series B Financing
Mar 24, 2023 04:57PM Form SC 13D/A CalciMedica, Inc. Filed by: ORBIMED ADVISORS LLC
Mar 24, 2023 04:43PM Form SC 13D/A 89bio, Inc. Filed by: ORBIMED ADVISORS LLC
Mar 22, 2023 04:28PM Form SC 13D/A CalciMedica Inc Filed by: ORBIMED ADVISORS LLC
Mar 14, 2023 04:19PM Form SC 13D/A Theseus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Mar 6, 2023 08:00AM Congruence Therapeutics Announces Close of Series A Extension, Bringing Total Round to Over US$65 Million
Feb 28, 2023 05:31PM Form SC 13D/A Fusion Pharmaceuticals Filed by: ORBIMED ADVISORS LLC
Feb 28, 2023 04:00PM Form SC 13D Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 27, 2023 08:31PM Form 4 Enliven Therapeutics, For: Feb 23 Filed by: ORBIMED ADVISORS LLC
Feb 23, 2023 03:23PM Form SC 13D/A Kinnate Biopharma Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:24PM Form SC 13G/A X4 Pharmaceuticals, Inc Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:21PM Form SC 13G/A VistaGen Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:17PM Form SC 13G Verastem, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:14PM Form SC 13G/A NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:12PM Form SC 13G/A VectivBio Holding AG Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:08PM Form SC 13G/A Theravance Biopharma, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:07PM Form SC 13G/A Sonendo, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:00PM Form SC 13G/A SI-BONE, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:58PM Form SC 13G/A Gracell Biotechnologies Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:56PM Form SC 13G/A Protara Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:56PM Form SC 13G/A RxSight, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:55PM Form SC 13G/A Jounce Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:47PM Form SC 13G/A Harpoon Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:46PM Form SC 13G Mersana Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:44PM Form SC 13G/A Mereo Biopharma Group Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:42PM Form SC 13G/A MeiraGTx Holdings plc Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:37PM Form SC 13G Kezar Life Sciences, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:24PM Form SC 13G/A Applied Therapeutics Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:19PM Form SC 13G ALX ONCOLOGY HOLDINGS Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:17PM Form SC 13G/A Crinetics Pharmaceutical Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:14PM Form SC 13G/A CATALYST BIOSCIENCES, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:13PM Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
Feb 14, 2023 04:03PM Form SC 13G/A Aeglea BioTherapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 7, 2023 09:00AM Garuda Therapeutics Secures $62 Million Series B Financing to Advance Off-the-Shelf Blood Stem Cell Technology Platform
Jan 26, 2023 04:41PM Form SC 13D/A 89bio, Inc. Filed by: ORBIMED ADVISORS LLC
Jan 20, 2023 09:26AM ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic
Jan 5, 2023 04:41PM Form SC 13D/A SpringWorks Therapeutics Filed by: ORBIMED ADVISORS LLC
Jan 4, 2023 08:00AM OnCusp Therapeutics Announces Appointment of Robert Forrester and Chau Khuong to Board of Directors
Jan 3, 2023 09:27PM Form 4 Disc Medicine, Inc. For: Dec 29 Filed by: ORBIMED ADVISORS LLC
Jan 3, 2023 09:23PM Form 3 Disc Medicine, Inc. For: Dec 29 Filed by: ORBIMED ADVISORS LLC
Jan 3, 2023 05:23PM Form SC 13D/A Disc Medicine, Inc. Filed by: ORBIMED ADVISORS LLC
Dec 29, 2022 08:30AM SINOVAC Reports Unaudited First Half of 2022 Financial Results
Dec 28, 2022 05:14PM Form SC 13D/A Terns Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Dec 27, 2022 05:39PM Form 4 Verona Pharma plc For: Dec 22 Filed by: ORBIMED ADVISORS LLC
Dec 27, 2022 04:37PM Form SC 13D/A Oric Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Dec 27, 2022 04:25PM Form SC 13D/A Verona Pharma plc Filed by: ORBIMED ADVISORS LLC
Nov 30, 2022 04:24PM Form SC 13D/A ARS Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Nov 30, 2022 08:06AM iECURE Raises $65 Million to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases
View More Recent Stories View Older Stories